Outcomes for trials of mucoactive therapy

Therapy for Mucus-Clearance Disorders

Volumn , Issue , 2004, Pages 87-103

  Rubin, Bruce K ^a   Van Der Schans, Cees P ^b  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b University for Professional Education   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 26844521430     PISSN: None     EISSN: None     Source Type: Book    
DOI: None     Document Type: Chapter

References (66)

1. Rubin BK. An in vitro comparison of the mucoactive properties of guaifenesin, iodinated glycerol, surfactant, and albuterol. Chest 1999; 116:195-200.
2. Kim JS, Hackley GH, Okamoto K, Rubin BK. Sputum processing for evaluation of inflammatory mediators. Pediatr Pulmonol 2001; 32:152-158.
3. Ripoll L, Reinert P. Pepin LF, Lagrange PH. Interaction of macrolides with alpha domase during DNA hydrolysis. J Antimicrob Chemother 1996; 37:987-991.
4. King M, Rubin BK. Mucus physiology and pathophysiology. In: Derenne JP, Whitelaw WA, Similowski T, eds. Acute Respiratory Failure in Chronic Obstructive Pulmonary Disease. New York: Marcel Dekker, 1996:391-411.
5. Rubin BK, Ramirez O, King M. Mucus-depleted frog palate as a model for the study of mucociliary clearance. J Appl Physiol 1990; 69:424-429.
6. Wills PJ, Garcia-Suarez MJ, Rutman A, Wilson R, Cole PJ. The ciliary transportability of sputum is slow on the mucus-depleted bovine trachea. Am J Respir Crit Care Med 1995; 151:1255-1258.
7. King M, Rubin BK. Mucus rheology, relationship with transport. In: Takishima T, Shimura S, eds. Airway Secretion: Physiological Bases for the Control of Mucous Hypersecretion. New York: Marcel Dekker, 1994:283-314.
8. King M. Relationship between mucus viscoelasticity and ciliary transport in guaran gel/frog palate model system. Biorheology 1980: 17:249-254.
9. Giordano A, Shih CK, Holsclaw DS. Khan MA, Litt M. Mucus clearance: in vivo canine tracheal vs. in vitro bullfrog palate studies. J Appl Physiol 1977; 42:761-766.
10. Puchelle E, Zahm JM, Girard F, Bertrand A, Polu JM. Aug F, et al. Mucociliary transport in vivo and in vitro. Relations to sputum properties in chronic bronchitis. Eur J Respir Dis 1980; 61:254-264.
11. Deneuville E, Perrot-Minot C, Pennaforte F, Roussey M, Zahm JM. Clavel C, et al. Revisited physicochemical and transport properties of respiratory mucus in ge-notyped cystic fibrosis patients. Am J Respir Crit Care Med 1997; 156:166-172.
12. Macchione M, King M, Lorenzi-Filho G, Guimaraes ET, Zin WA. Bohm GM, et al. Rheological determinants of mucociliary transport in the nose of the rat. Respir Physiol 1995; 99:165-172.
13. Agarwal M, King M, Rubin BK, Shukla JB. Mucus transport in a miniaturized simulated cough machine: effect of constriction and serous layer simulant. Biorheology 1989; 26:977-988.
14. King M. Zahm JM, Pierrot D. Vaquez-Girod S, Puchelle E. The role of mucus gel viscosity, spinnability, and adhesive properties in clearance by simulated cough. Biorheology 1989; 26:737-745.
15. Zahm JM, Pierrot D, Vaquez-Girod S, Duvivier C, King M, Puchelle E. The role of mucus sol phase in clearance by simulated cough. Biorheology 1989; 26:747-752.
16. Albers GM, Tomkiewicz RP. May MK, Ramirez OE, Rubin BK. Ring distraction technique for measuring surface tension of sputum: relationship to sputum dear-ability. J Appl Physiol 1996; 81:2690-2695.
17. Girod S, Galabert C, Pierrot D, Boissonnade MM, Zahm JM, Baszkin A, et al. Role of phospholipid lining on respiratory mucus clearance by cough. J Appl Physiol 1991; 71:2262-2266.
18. Puchelle E, Zahm JM, Duvivier C. Spinability of bronchial mucus. Relationship with viscoelasticity and mucous transport properties. Biorheology 1983; 20:239-249.
19. Rubin BK. Surface properties of respiratory secretions: relationship to mucus transport. In: Baum GL, Priel Z, Roth Y. Liron N, Ostfeld EJ, eds. Cilia, Mucus, and Mucociliary Interactions. New York: Marcel Dekker, 1998:317-324.
20. Wooten R. Biophysical properties and polymeric structure of artificial mucus and sputum produced by copolymerizing mucin and DNA. 2000.
21. Kishioka C, Okamoto K, Kim J, Rubin BK. Regulation of secretion from mucous and serous cells in the excised ferret trachea. Respir Physiol 2001; 126:163-171.
22. Rubin BK, Tomkiewicz RP, King M. Mucoactive agents. In: Wilmott RW, ed. The Pediatric Lung. Basel, Switzerland: Birkhauser Publishing, 1997:155-179.
23. van der Schans CP, Postma DS, Koeter GH, Rubin BK. Physiotherapy and bronchial mucus transport. Eur Respir J 1999; 13:1477-1486.
24. Reid L. An experimental study of hypersecretion of mucus in the bronchial tree. Br J Exp Path 1963; 44:437-445.
25. Cochrane GM, Webber BA, Clarke SW. Effects of sputum on pulmonary function. Br Med J 1977: 2:1181-1183.
26. Oldenburg FA Jr., Dolovich MB, Montgomery JM. Newhouse MT. Effects of postural drainage, exercise, and cough on mucus clearance in chronic bronchitis. Am Rev Respir Dis 1979; 120:739-745.
27. May DB, Munt PW. Physiologic effects of chest percussion and postural drainage in patients with stable chronic bronchitis. Chest 1979; 75:29-32.
28. Maloney FP, Fernandez E, Hudgel DW. Postural drainage effect after bronchodila-tor inhalation in patients with chronic airway obstruction. Arch Phys Med Rehabil1981; 62:452-455.
29. Mazzocco MC, Owens GR, Kirilloff LH, Rogers RM. Chest percussion and postural drainage in patients with bronchiectasis. Chest 1985; 88:360-363.
30. Gallon A. Evaluation of chest percussion in the treatment of patients with copious sputum production. Respir Med 1991; 85:45-51.
31. van Hengstum M, Festen J. Beurskens C. Hankel M, van den Broek W, Buijs W, et al. The effect of positive expiratory pressure versus forced expiration technique on tracheobronchial clearance in chronic bronchitics. Scand J Gastroenterol Suppl 1988; 143:114-118.
32. Sutton PP. Gemmell HG. Innes N, Davidson J. Smith FW, Legge JS, et al. Use of nebulised saline and nebulised terbutaline as an adjunct to chest physiotherapy. Thorax 1988; 43:57-60.
33. van Hengstum M, Festen J, Beurskens C, Hankel M, van den Broek W, Corstens F. No effect of oral high frequency oscillation combined with forced expiration manoeuvres on tracheobronchial clearance in chronic bronchitis. Eur Respir J 1990; 3:14-18.
34. Regnis JA, Alison JA, Henke KG, Donnelly PM, Bye PT. Changes in end-expiratory lung volume during exercise in cystic fibrosis relate to severity of lung disease. Am Rev Respir Dis 1991: 144(3 pt 1):507-512.
35. Vereen LE, Payne DK, George RB. Unilateral absence of ventilation and perfusion associated with a bronchial mucous plug. South Med J 1987; 80:391-393.
36. Pham DH, Huang D, Korwan A, Greyson ND. Acute unilateral pulmonary nonventilation due to mucous plugs. Radiology 1987; 165:135-137.
37. Bray ST, Johnstone WH, Dee PM, Pope TL, Jr., Teates CD, Tegtmeyer CJ. The “mucous plug syndrome”: a pulmonary embolism mimic. Clin Nucl Med 1984; 9: 513-518.
38. Dee PM, Suratt PM, Bray ST, Rose CE, Jr. Mucous plugging simulating pulmonary embolism in patients with quadriplegia. Chest 1984; 85:363-366.
39. Mortensen J, Falk M, Groth S. Jensen C. The effects of postural drainage and positive expiratory pressure physiotherapy on tracheobronchial clearance in cystic fibrosis. Chest 1991; 100:1350-1357.
40. Konrad FX, Schreiber T, Brecht Kraus D, Georgieff M. Bronchial mucus transport in chronic smokers and nonsmokers during general anesthesia. J Clin Anesth 1993; 5:375-380.
41. Zwas ST, Katz I, Belfer B. Baum GL. Aharonson E. Scintigraphic monitoring of mucociliary tracheo-bronchial clearance of technetium-99m macroaggregated albumin aerosol. J Nucl Med 1987; 28:161-167.
42. Ilowite JS, Smaldone GC, Perry RJ. Bennett WD. Foster WM. Relationship between tracheobronchial particle clearance rates and sites of initial deposition in man. Arch Environ Health 1989; 44:267-273.
43. Bjure J. Ergometry and physical training in pediatrics with special reference to pulmonary function. Acta Paediatr Scand Suppl 1971; 217:56-59.
44. Thomson ML, Pavia D. Particle penetration and clearance in the human lung. Results in healthy subjects and subjects with chronic bronchitis. Arch Environ Health1974; 29:214-219.
45. Vestbo J, Prescott E, Lange P. Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group. Am J Respir Crit Care Med 1996; 153:1530-1535.
46. Lange P, Vestbo J, Nyboe J. Risk factors for death and hospitalization from pneumonia. A prospective study of a general population. Eur Respir J 1995; 8:1694-1698.
47. Prescott E, Lange P, Vestbo J. Chronic mucus hypersecretion in COPD and death from pulmonary infection. Eur Respir J 1995; 8:1333-1338.
48. Christensen EF, Nedergaard T, Dahl R. Long-term treatment of chronic bronchitis with positive expiratory pressure mask and chest physiotherapy. Chest 1990; 97: 645-650.
49. Christensen HR, Simonsen K, Lange P, Clementsen P, Kampmann JP, Viskum K, et al. PEEP-masks in patients with severe obstructive pulmonary disease: a negative report. Eur Respir J 1990; 3:267-272.
50. Reisman JJ, Rivington Law B, Corey M. Marcotte J, Wannamaker E, Harcourt D, et al. Role of conventional physiotherapy in cystic fibrosis. J Pediatr 1988; 113: 632-636.
51. Mcllwaine PM, Wong LT, Peacock D, Davidson AG. Long-term comparative trial of conventional postural drainage and percussion versus positive expiratory pressure physiotherapy in the treatment of cystic fibrosis. J Pediatr 1997; 131:570-574.
52. McGavin CR, Gupta SP, McHardy GJ. Twelve-minute walking test for assessing disability in chronic bronchitis. Br Med J 1976; 1:822-823.
53. Singh SJ, Morgan MD, Scott S, Walters D, Hardman AE. Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax 1992; 47:1019-1024.
54. Balfour-Lynn IM, Prasad SA, Laverty A, Whitehead BF. Dinwiddie R. A step in the right direction: assessing exercise tolerance in cystic fibrosis. Pediatr Pulmonol1998; 25:278-284.
55. Redelmeier DA, Bayoumi AM, Goldstein RS, Guyatt GH. Interpreting small differences in functional status: the Six Minute Walk test in chronic lung disease patients. Am J Respir Crit Care Med 1997; 155:1278-1282.
56. Killian KJ, Gandevia SC, Summers E, Campbell EJ. Effect of increased lung volume on perception of breathlessness, effort, and tension. J Appl Physiol 1984; 57: 686-691.
57. Mahler DA, Rosiello RA. Harver A, Lentine T, McGovern JF. Daubenspeck JA. Comparison of clinical dyspnea ratings and psychophysical measurements of respiratory sensation in obstructive airway disease. Am Rev Respir Dis 1987; 135: 1229-1233.
58. Mahler DA, Mackowiak JI. Evaluation of the short-form 36-item questionnaire to measure health-related quality of life in patients with COPD. Chest 1995; 107: 1585-1589.
59. Congleton J, Hodson ME, Duncan Skingle F. Do Nottingham Health Profile scores change over time in cystic fibrosis? Respir Med 1998; 92:268-272.
60. Congleton J, Hodson ME, Duncan Skingle F. Quality of life in adults with cystic fibrosis. Thorax 1996; 51:936-940.
61. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992; 145:1321-1327.
62. Guyatt GH, Berman LB, Townsend M, Pugsley SO. Chambers LW. A measure of quality of life for clinical trials in chronic lung disease. Thorax 1987; 42:773-778.
63. Hyland ME, Singh SJ, Sodergren SC, Morgan MP. Development of a shortened version of the Breathing Problems Questionnaire suitable for use in a pulmonary rehabilitation clinic: a purpose-specific, disease-specific questionnaire. Qual Life Res 1998: 7:227-233.
64. Petty TL. The National Mucolytic Study. Results of a randomized, double- blind, placebo-controlled study of iodinated glycerol in chronic obstructive bronchitis. Chest 1990; 97:75-83.
65. Piquette CA. Clarkson L, Okamoto K. Kim JS, Rubin BK. Respiratory-related quality of life: relation to pulmonary function, functional exercise capacity, and sputum biophysical properties. J Aerosol Med 2000; 13:263-272.
66. Mcllwaine PM, Wong LT, Peacock D. Davidson AG. Long-term comparative trial of conventional postural drainage and percussion versus positive expiratory pressure physiotherapy in the treatment of cystic fibrosis. J Pediatr 1997; 131:570-574.